Clinical Study

Patient-Specific Total Knee Replacement with Conformis Technology Is More Cost-Effective Than with Leading Off-the-Shelf Implants - Seite 2

“It is very gratifying to see Conformis technology once again demonstrate its superior performance, as presented at the ORS 2021 Annual Meeting,” said Mark Augusti, President and Chief Executive Officer, Conformis, Inc. “By designing and manufacturing Conformis iTotal knee replacement implants to fit each individual’s unique anatomy, patients, surgeons, and medical facilities benefit from expedited surgeries and shorter hospital lengths of stay. Conformis iTotal implants help to relieve chronic joint pain, while also driving savings for hospitals and insurance providers.”

The median patient age was 66 years old, and the median BMI was 31 for the three groups.

Mean LOS analysis:

• 1.35 days for Conformis iTotal patients
• 1.99 days for Zimmer Persona patients
• 1.83 for Stryker Triathlon patients
  

Total direct costs analysis:

• $9,341 for Conformis iTotal patients (savings of $1,006 to $1,263 per patient)
• $10,347 for Zimmer Persona patients
• $10,604 for Stryker Triathlon patients
  

There was no apparent difference in morphine equivalent dose use amongst the three groups.

The study concludes that total direct costs for hospital admissions appear to be more cost-effective with the Conformis iTotal System, and variables such as operative time and LOS also appear to favor a patient-specific implant over traditional, off-the-shelf implants.

Three other comparative studies published between 2017 and 2019 also demonstrate that Conformis iTotal implants drive savings for hospitals and insurance companies:

• O’Connor, Mary, and Blau, Brittany, “Assessing the Economic Value of Custom Implants." American Health & Drug Benefits. 2019, Vol.12, No. 2.
• Richard G. Buch, M.D., Robert W. Eberle, Jason Davis, M.D., and Rylie Buch, MS, “Does Implant Design Affect Hospital Metrics and Patents Outcomes? TKA Utilizing a ‘Fast-Track’ Protocol.” Reconstructive Review. 2019, Vol. 9 No. 1.
• Culler et al., “Comparison of Adverse Event Rates and Hospital Costs Between Customized Individually Made Implants and Standard Off-the-Shelf Implants for Total Knee Arthroplasty.” Arthroplasty Today 2017.
  

About Conformis, Inc.

Conformis is a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture, and sell joint replacement implants and instruments that are individually sized and shaped, which we refer to as personalized, individualized, or sometimes as customized, to fit each patient’s unique anatomy. Conformis offers a broad line of sterile, personalized knee and hip implants and single-use instruments delivered to hospitals and ambulatory surgical centers. In clinical studies, the Conformis iTotal CR knee replacement system demonstrated superior clinical outcomes, including better function and greater patient satisfaction, compared to traditional, off-the-shelf implants. Conformis owns or exclusively in-licenses issued patents and pending patent applications that cover personalized implants and patient-specific instrumentation for all major joints.